Literature DB >> 29285750

The Use of Stem Cell Therapy to Reverse Opioid Tolerance.

Fei Li1,2, LiPing Liu2, Kathleen Cheng2, Zhongbo Chen1, Jianguo Cheng2.   

Abstract

Opioid tolerance (OT) and opioid-induced hyperalgesia (OIH) are major challenges in medicine. Here we report that transplantation of mesenchymal stem cells (MSCs) prevented and reversed OT and OIH in rats and mice. The preventive and therapeutic effects were long-lasting and consistent across different assessment schemes. Both intrathecal and intravenous transplantations were effective and safe. This emerging therapeutic strategy has thus shown promise to impact clinical practice and improve the efficacy and safety of opioid therapy.
© 2018 American Society for Clinical Pharmacology and Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29285750     DOI: 10.1002/cpt.959

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  3 in total

Review 1.  Neuroimmune modulation of pain and regenerative pain medicine.

Authors:  Thomas Buchheit; Yul Huh; William Maixner; Jianguo Cheng; Ru-Rong Ji
Journal:  J Clin Invest       Date:  2020-05-01       Impact factor: 14.808

Review 2.  Modulatory Effects of Stem Cells on Opioid Receptors and Neuroinflammation.

Authors:  Matthew Meroney; Joshua Winegar; Holden Brown; Mark Bender; Scott Smith; Rene Przkora
Journal:  Curr Pain Headache Rep       Date:  2022-02-05

Review 3.  Mesenchymal Stromal Cell Therapy in Spinal Cord Injury: Mechanisms and Prospects.

Authors:  Ji-Le Xie; Xing-Ran Wang; Mei-Mei Li; Zi-Han Tao; Wen-Wen Teng
Journal:  Front Cell Neurosci       Date:  2022-06-03       Impact factor: 6.147

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.